Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile

Abroad (travel likely)Recruiting

Conditions

Clostridium Difficile Infection Recurrence · Clostridium Difficile Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UMass Memorial Medical Center, Worcester, Massachusetts, United States
Contact: Study coordinator (Anne Foley) · Anne.Foley@umassmed.edu
Contact: Principal Investigator (Krunal Patel, MD)

Study leads

Krunal Patel
Principal Investigator
UMass Medical School

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach

Clostridium Difficile · Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Rome, Italy

Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics

Clostridium Difficile Infection Recurrence · Ulcerative Colitis (UC) · Crohn Disease (CD)

Abroad (travel likely)Recruiting

Shanghai, China

Fecal Microbiota Transplantation for C Diff Infection

Clostridium Difficile Infection

Abroad (travel likely)Recruiting

Englewood, United States

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Clostridium Difficile · Clostridium Difficile Infections · Clostridium Difficile Infection Recurrence

IsraelRecruitingPHASE3

Huntsville, United States · Chandler, United States